The scientific community has raised concerns about the state of UK immigration after a number of academics attending the Global Symposium on Health Systems Research were denied access to the country recently. At least 10 of the 200 attendees were affected by the policy, with arguments raised that such policies could impact academic co-operation.
A database of normal human immunity has been created by scientists at UC San Francisco, creating an instant comparison group to let researchers use in studies of the immune system and immune dysfunction.
Braden van der Wall and Steven Romanoff, allege that Illumina artificially inflated their stock price through misreporting the company’s earnings in Q3 2016.
For the first time, scientists have performed prenatal gene editing to prevent a lethal metabolic disorder in laboratory animals, offering the potential to treat human congenital diseases before birth.
The Secretary of State for Health and Social Care in the UK, the Rt Hon Matt Hancock MP, has announced plans for the NHS to sequence 5 million genomes over 5 years.
The 2018 Nobel Prize for Physiology or Medicine has been awarded to James Allison and Tasuku Honjo for their work on cancer immunotherapy.
The NIH has awarded inaugural funding to three institutions to establish a new genome centre for the All of Us Research Program.
Rady Children’s Hospital has launched a new, California State-funded initiative called Project Baby Bear to cover rWGS for critically ill newborns across the state.
SOPHiA GENETICS has announced that they are opening a new headquarters in Boston, Massachusetts to accommodate growing US demand.
ASCO checkpoint inhibitor battle between Merck and Roche highlights the pitfalls in directly comparing clinical trial results in the era of precision medicine.
Precision medicine is showing significant signs of success across tumour types.
Researchers have discovered a new class of anti-cancer drugs that can stop specific cancer cells from proliferating—putting them to “sleep,” potentially permanently.
Despite representing over 40% of the global population, Asians are vastly underrepresented in genetic databases contributing around 1%. We take a look at how FDNA, and other key players are changing this.
Researchers at the Key Laboratory of Synthetic Biology in Shanghai have used CRISPR to create a new species of yeast that only has a single giant chromosome.
Scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?